Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Yahoo! Finance
Total Operating Expenses: $14.7 million for Q4 2025; $54.9 million for the full year 2025. Net Loss: $14.7 million for Q4 2025; $54.7 million for the full year 2025. Release Date: March 24, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Achieve Life Sciences Inc ( NASDAQ:ACHV ) submitted a New Drug Application (NDA) for Cytisinicline, marking a significant step towards becoming the first new FDA-approved treatment for smoking cessation in 20 years. The company received a Commissioner's National Priority Voucher for its vaping cessation indication, providing an accelerated pathway for FDA approval. Clinical trials, including the ORCA-OL long-term exposure trial, demonstrated Cytisinicline's strong safety profile and patient satisfaction. Achieve Life Sciences Inc ( NASDAQ:ACHV ) is building a scalable, data-driven commercial model using AI to enhance decision-making and customer engagement. The
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable TolerabilityGlobeNewswire
- Achieve Life Sciences (ACHV) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
- Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Achieve Life Sciences GAAP EPS of -$0.28 misses by $0.01 [Seeking Alpha]Seeking Alpha
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
ACHV
Earnings
- 3/24/26 - Miss
ACHV
Analyst Actions
- 3/25/26 - HC Wainwright
ACHV
Sec Filings
- 3/24/26 - Form S-8
- 3/24/26 - Form 10-K
- 3/24/26 - Form 8-K
- ACHV's page on the SEC website